Prospective, Randomized Phase II Study Comparing Two Elution Rates of Glaukos Travoprost Intraocular Implants to Timolol Maleate Ophthalmic Solution, USP, 0.5%
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Travoprost (Primary) ; Timolol
- Indications Glaucoma
- Focus Therapeutic Use
- Sponsors Glaukos Corporation
- 14 Sep 2017 According to a Glaukos Corporation media release, the subjects will be followed through three years.
- 14 Sep 2017 Preliminary results published in a Glaukos Corporation media release.
- 15 Mar 2016 Status changed from not yet recruiting to recruiting.